<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39468120</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>29</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>28</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 variants induce increased inflammatory gene expression but reduced interferon responses and heme synthesis as compared with wild type strains.</ArticleTitle><Pagination><StartPage>25734</StartPage><MedlinePgn>25734</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-024-76401-1</ELocationID><Abstract><AbstractText>SARS-CoV-2 variants of concern (VOC) have been associated with increased viral transmission and disease severity. We investigated the mechanisms of pathogenesis caused by variants using a host blood transcriptome profiling approach. We analysed transcriptional signatures of COVID-19 patients comparing those infected with wildtype (wt), alpha, delta or omicron strains seeking insights into infection in Asymptomatic cases.Comparison of transcriptional profiles of Symptomatic and Asymptomatic COVID-19 cases showed increased differentially regulated gene (DEGs) of inflammatory, apoptosis and blood coagulation pathways, with decreased T cell and Interferon stimulated genes (ISG) activation. Between SARS-CoV-2 strains, an increasing number of DEGs occurred in comparisons between wt and alpha (196), delta (1425) or, omicron (2313) infections. COVID-19 cases with alpha or, delta variants demonstrated suppression transcripts of innate immune pathways. EGR1 and CXCL8 were highly upregulated in those infected with VOC; heme biosynthetic pathway genes (ALAS2, HBB, HBG1, HBD9) and ISGs were downregulated. Delta and omicron infections upregulated ribosomal pathways, reflecting increased viral RNA translation. Asymptomatic COVID-19 cases infected with delta infections showed increased cytokines and ISGs expression. Overall, increased inflammation, with reduced host heme synthesis was associated with infections caused by VOC infections, with raised type I interferon in cases with less severe disease.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Merchant</LastName><ForeName>Mariam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Javaria</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masood</LastName><ForeName>Kiran Iqbal</ForeName><Initials>KI</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yameen</LastName><ForeName>Maliha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussain</LastName><ForeName>Rabia</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasir</LastName><ForeName>Asghar</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasan</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan. zahra.hasan@aku.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>GCF-913</GrantID><Agency>Higher Education Commission, Pakistan</Agency><Country /></Grant><Grant><GrantID>GCF-913</GrantID><Agency>Higher Education Commission, Pakistan</Agency><Country /></Grant><Grant><GrantID>GCF-913</GrantID><Agency>Higher Education Commission, Pakistan</Agency><Country /></Grant><Grant><GrantID>GCF-913</GrantID><Agency>Higher Education Commission, Pakistan</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>42VZT0U6YR</RegistryNumber><NameOfSubstance UI="D006418">Heme</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006418" MajorTopicYN="Y">Heme</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059467" MajorTopicYN="N">Transcriptome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALAS2</Keyword><Keyword MajorTopicYN="N">Delta variant</Keyword><Keyword MajorTopicYN="N">EGR1</Keyword><Keyword MajorTopicYN="N">ISG</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Variants of concern</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>29</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39468120</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-76401-1</ArticleId><ArticleId IdType="pii">10.1038/s41598-024-76401-1</ArticleId></ArticleIdList><ReferenceList><Title /><Reference><Citation>JHU. Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html (2023).</Citation></Reference><Reference><Citation>Zhao, D. et al. A comparative study on the clinical features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias. Clin. Infect. Dis. 71(15), 756–761 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32161968</ArticleId><ArticleId IdType="doi">10.1093/cid/ciaa247</ArticleId></ArticleIdList></Reference><Reference><Citation>Korber, B. et al. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 Virus. Cell. 182(4), 812–827e19 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32697968</ArticleId><ArticleId IdType="pmc">7332439</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2020.06.043</ArticleId></ArticleIdList></Reference><Reference><Citation>Aldridge, R. W. et al. SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort. Nat. Commun. 13(1), 4869 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35982056</ArticleId><ArticleId IdType="pmc">9387883</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-32265-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, H. H. &amp; Stone, D. H. Watching Brief: The evolution and impact of COVID-19 variants B. 1.1. 7, B. 1.351, P. 1 and B. 1.617. Glob. Biosecurity. 3 (2021).</Citation></Reference><Reference><Citation>Nasir, A. et al. Tracking SARS-CoV-2 variants through pandemic waves using RT-PCR testing in low-resource settings. PLOS Glob Public. Health. 3(6), e0001896 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37262051</ArticleId><ArticleId IdType="pmc">10234525</ArticleId><ArticleId IdType="doi">10.1371/journal.pgph.0001896</ArticleId></ArticleIdList></Reference><Reference><Citation>Umair, M. et al. Genomic surveillance reveals the detection of SARS-CoV‐2 delta, beta, and gamma VOCs during the third wave in Pakistan. J. Med. Virol. 94(3), 1115–1129 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34726786</ArticleId><ArticleId IdType="doi">10.1002/jmv.27429</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren, W. et al. Characterization of SARS-CoV-2 variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by cell entry and immune evasion. mBio, e0009922. (2022).</Citation></Reference><Reference><Citation>Lambrou, A. S. et al. Genomic surveillance for SARS-CoV-2 variants: predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) variants - United States, June 2021-January 2022. MMWR Morb Mortal. Wkly. Rep. 71(6), 206–211 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35143464</ArticleId><ArticleId IdType="pmc">8830620</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7106a4</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, D. et al. The global epidemic of the SARS-CoV-2 Delta variant, key spike mutations and Immune escape. Front. Immunol. 12, 751778 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34917076</ArticleId><ArticleId IdType="pmc">8669155</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.751778</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng, Y. et al. Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21(11), 1336–1345 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32887977</ArticleId><ArticleId IdType="pmc">7611020</ArticleId><ArticleId IdType="doi">10.1038/s41590-020-0782-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Mushtaq, M. Z. et al. Exploring the relationship between SARS-CoV-2 variants, illness severity at presentation, in-hospital mortality and COVID-19 vaccination in a low middle-income country: a retrospective cross-sectional study. Health Sci. Rep., 6(12). (2023).</Citation></Reference><Reference><Citation>Masood, K. I. et al. Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan. BMC Infect. Dis. 23(1), 846 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38041026</ArticleId><ArticleId IdType="pmc">10691108</ArticleId><ArticleId IdType="doi">10.1186/s12879-023-08829-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, P. et al. The trans-omics landscape of COVID-19. Nat. Commun. 12(1), 4543 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34315889</ArticleId><ArticleId IdType="pmc">8316550</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-24482-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, P. et al. Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencing. Int. Immunopharmacol. 108, 108767 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35453072</ArticleId><ArticleId IdType="pmc">9013654</ArticleId><ArticleId IdType="doi">10.1016/j.intimp.2022.108767</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, X. et al. Dysregulated hematopoiesis in bone marrow marks severe COVID-19. Cell. Discov. 7(1), 60 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34349096</ArticleId><ArticleId IdType="pmc">8335717</ArticleId><ArticleId IdType="doi">10.1038/s41421-021-00296-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Masood, K. I. et al. Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcome. Sci. Rep. 11(1), 22958 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34824360</ArticleId><ArticleId IdType="pmc">8617268</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-02489-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Armignacco, R. et al. Whole blood transcriptome signature predicts severe forms of COVID-19: results from the COVIDeF cohort study. Funct. Integr. Genomics. 24(3), 107 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38772950</ArticleId><ArticleId IdType="pmc">11108918</ArticleId><ArticleId IdType="doi">10.1007/s10142-024-01359-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Du, T. et al. Differential transcriptomic landscapes of SARS-CoV-2 variants in multiple organs from infected Rhesus macaques. Genomics Proteom. Bioinf. 21(5), 1014–1029 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2023.06.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh, T. et al. Comparative spatial transcriptomic profiling of severe acute respiratory syndrome coronavirus 2 Delta and Omicron variants infections in the lungs of cynomolgus macaques. J. Med. Virol. 95(6), e28847 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37272485</ArticleId><ArticleId IdType="doi">10.1002/jmv.28847</ArticleId></ArticleIdList></Reference><Reference><Citation>Organization, W. H. Ordinal Scale for Clinical Improvement. (2020).</Citation></Reference><Reference><Citation>Ghanchi, N. K. et al. Higher entropy observed in SAR-CoV-2 genomes from the first COVID-19 wave in Pakistan. PLoS ONE. 16(8), e0256451 https://doi.org/10.1371/journal.pone.0256451 (2021).</Citation></Reference><Reference><Citation>Zhang, J. et al. Role of TCF-1 in differentiation, exhaustion, and memory of CD8(+) T cells: a review. FASEB J. 35(5), e21549 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33913198</ArticleId><ArticleId IdType="doi">10.1096/fj.202002566R</ArticleId></ArticleIdList></Reference><Reference><Citation>Canfran-Duque, A. et al. Macrophage-derived 25-hydroxycholesterol promotes vascular inflammation, atherogenesis, and Lesion Remodeling. Circulation. 147(5), 388–408 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36416142</ArticleId><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.059062</ArticleId></ArticleIdList></Reference><Reference><Citation>Henriquez, K. M. et al. Association of interleukin-8 and neutrophils with nasal symptom severity during acute respiratory infection. J. Med. Virol. 87(2), 330–337 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25132248</ArticleId><ArticleId IdType="doi">10.1002/jmv.24042</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschenbrenner, A. C. et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 13(1), 7 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33441124</ArticleId><ArticleId IdType="pmc">7805430</ArticleId><ArticleId IdType="doi">10.1186/s13073-020-00823-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer, B. et al. Early IFN-alpha signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19. (2021).</Citation></Reference><Reference><Citation>Zhang, J. et al. Transcriptome changes of hematopoietic stem and progenitor cells in the Peripheral blood of COVID-19 patients by scRNA-seq. Int. J. Mol. Sci., 24(13). (2023).</Citation></Reference><Reference><Citation>Busse, D. C. et al. Interferon-induced protein 44 and interferon-induced protein 44-like restrict replication of respiratory syncytial virus. J. Virol., 94(18). (2020).</Citation></Reference><Reference><Citation>Schoggins, J. W. &amp; Rice, C. M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1(6), 519–525 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22328912</ArticleId><ArticleId IdType="pmc">3274382</ArticleId><ArticleId IdType="doi">10.1016/j.coviro.2011.10.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian, Q. &amp; Sun, B. Interferons command Trim22 to fight against viruses. Cell. Mol. Immunol. 14(9), 794–796 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28782753</ArticleId><ArticleId IdType="pmc">5596251</ArticleId><ArticleId IdType="doi">10.1038/cmi.2017.76</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19(7), 409–424 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34075212</ArticleId><ArticleId IdType="pmc">8167834</ArticleId><ArticleId IdType="doi">10.1038/s41579-021-00573-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodson, C. M. &amp; Kehn-Hall, K. Examining the role of EGR1 during viral infections. Front. Microbiol. 13, 1020220 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36338037</ArticleId><ArticleId IdType="pmc">9634628</ArticleId><ArticleId IdType="doi">10.3389/fmicb.2022.1020220</ArticleId></ArticleIdList></Reference><Reference><Citation>Laine, L. et al. SARS-CoV-2 variants alpha, Beta, Delta and Omicron show a slower host cell interferon response compared to an early pandemic variant. Front. Immunol. 13, 1016108 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36248817</ArticleId><ArticleId IdType="pmc">9561549</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1016108</ArticleId></ArticleIdList></Reference><Reference><Citation>John, S. P. et al. IFIT1 exerts Opposing Regulatory effects on the inflammatory and Interferon Gene Programs in LPS-Activated human macrophages. Cell. Rep. 25(1), 95–106e6 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30282041</ArticleId><ArticleId IdType="pmc">6492923</ArticleId><ArticleId IdType="doi">10.1016/j.celrep.2018.09.002</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, S. Regulation of ribosomal proteins on viral infection. Cells, 8(5). (2019).</Citation></Reference><Reference><Citation>Ong, S. W. X. et al. Clinical and virological features of severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) variants of concern: a retrospective cohort study comparing B.1.1.7 (alpha), B.1.351 (Beta), and B.1.617.2 (Delta). Clin. Infect. Dis. 75(1), e1128–e1136 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34423834</ArticleId><ArticleId IdType="doi">10.1093/cid/ciab721</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg, T. et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 399(10332), 1303–1312 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35305296</ArticleId><ArticleId IdType="pmc">8926413</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Mwendwa, F. et al. Shift in SARS-CoV-2 variants of concern from Delta to Omicron was associated with reduced hospitalizations, increased risk of breakthrough infections but lesser disease severity. J. Infect. Public. Health. 17(6), 1100–1107 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38714122</ArticleId><ArticleId IdType="pmc">11142923</ArticleId><ArticleId IdType="doi">10.1016/j.jiph.2024.04.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, J. et al. Association between Red Blood cell distribution width and COVID-19 severity in Delta variant SARS-CoV-2 infection. Front. Med. (Lausanne). 9, 837411 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35265643</ArticleId><ArticleId IdType="doi">10.3389/fmed.2022.837411</ArticleId></ArticleIdList></Reference><Reference><Citation>Laha, S. et al. Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission. Infect. Genet. Evol. 85, 104445 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32615316</ArticleId><ArticleId IdType="pmc">7324922</ArticleId><ArticleId IdType="doi">10.1016/j.meegid.2020.104445</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi, F. et al. Single-cell analysis of the adaptive immune response to SARS-CoV-2 infection and vaccination. Front. Immunol. 13, 964976 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36119105</ArticleId><ArticleId IdType="pmc">9478577</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.964976</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. et al. Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection. J. Med. Virol. 94(11), 5304–5324 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35859327</ArticleId><ArticleId IdType="pmc">9350186</ArticleId><ArticleId IdType="doi">10.1002/jmv.28012</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann-Weiler, R. et al. Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in patients with COVID-19 infection. J. Clin. Med., 9(8). (2020).</Citation></Reference><Reference><Citation>Maurya, R. et al. Intertwined dysregulation of ribosomal proteins and immune response delineates SARS-CoV-2 vaccination breakthroughs. Microbiol. Spectr. 11(3), e0429222 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37022180</ArticleId><ArticleId IdType="doi">10.1128/spectrum.04292-22</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandel, D. et al. SARS-CoV-2 variant delta potently suppresses innate immune response and evades Interferon-activated antiviral responses in human colon epithelial cells. Microbiol. Spectr. 10(5), e0160422 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36073824</ArticleId><ArticleId IdType="doi">10.1128/spectrum.01604-22</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenquer, M. et al. Signatures in SARS-CoV-2 spike protein conferring escape to neutralizing antibodies. PLoS Pathog. 17(8), e1009772 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34352039</ArticleId><ArticleId IdType="pmc">8341613</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1009772</ArticleId></ArticleIdList></Reference><Reference><Citation>Challen, R. et al. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMJ. 372, n579 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33687922</ArticleId><ArticleId IdType="doi">10.1136/bmj.n579</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka, C. K. V. et al. SARS-CoV-2 variant of concern P.1 (Gamma) infection in young and middle-aged patients admitted to the intensive care units of a single hospital in Salvador, northeast Brazil, February 2021. Int. J. Infect. Dis. (2021).</Citation></Reference><Reference><Citation>Bukhari, A. R. et al. Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave. BMC Genom. 24(1), 432 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12864-023-09539-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasir, A. et al. Evolutionary history and introduction of SARS-CoV-2 Alpha VOC/B.1.1.7 in Pakistan through international travelers. Virus Evol. 8(1), veac020 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35462736</ArticleId><ArticleId IdType="pmc">9021734</ArticleId><ArticleId IdType="doi">10.1093/ve/veac020</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang da, W., Sherman, B. T. &amp; Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37(1), 1–13 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19033363</ArticleId><ArticleId IdType="doi">10.1093/nar/gkn923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947–1951 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31441146</ArticleId><ArticleId IdType="pmc">6798127</ArticleId><ArticleId IdType="doi">10.1002/pro.3715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M. &amp; Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28(1), 27–30 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10592173</ArticleId><ArticleId IdType="doi">10.1093/nar/28.1.27</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51(D1), D587–D592 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36300620</ArticleId><ArticleId IdType="doi">10.1093/nar/gkac963</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, G. et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 16(5), 284–287 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22455463</ArticleId><ArticleId IdType="pmc">3339379</ArticleId><ArticleId IdType="doi">10.1089/omi.2011.0118</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, G. et al. DOSE: an R/Bioconductor package for disease ontology semantic and enrichment analysis. Bioinformatics. 31(4), 608–609 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25677125</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btu684</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, G. Enrichplot: Visualization of Functional Enrichment Result (p. R package, 2021).</Citation></Reference><Reference><Citation>Luo, W. &amp; Brouwer, C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics. 29(14), 1830–1831 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23740750</ArticleId><ArticleId IdType="pmc">3702256</ArticleId><ArticleId IdType="doi">10.1093/bioinformatics/btt285</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak, K. J. &amp; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25(4), 402–408 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId><ArticleId IdType="doi">10.1006/meth.2001.1262</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>